Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-813

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 67457-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure of daptomycin, the active ingredient in the injection, powder, lyophilized, for solution product formulated for intravenous use by Mylan Institutional LLC.*
FDA Label Image

Carton (Image 02)

Carton (Image 02)
Packaging label for Daptomycin injection, 500 mg/vial, lyophilized powder for solution, manufactured by Mylan Institutional LLC. The label specifies refrigeration requirements, intravenous infusion route, and reconstitution instructions using 10 mL 0.9% Sodium Chloride Injection. Marked as a single-dose vial and Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.